Cardiac and Digestive Forms of Chagas Disease: An Update on Pathogenesis, Genetics, and Therapeutic Targets
Mediators of Inflammation · 2025-01 · 2025 (1)
DOI: 10.1155/mi/8862004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mediators of Inflammation, online erschienen am 21.04.2025. Verfasst von Amanda Farage Frade und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunology, Heart Institute (InCor), University of São Paulo Medical School, São Paulo 05403-900, Brazil. Hauptthemen laut MEDLINE: Chagas Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale, Aix-Marseille Université, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi ( T. cruzi ), is a neglected disease affecting around 6 million people, with no effective antiparasitic drugs or vaccines. About 40% of Chagas disease patients develop symptomatic forms in the chronic phase of infection, chronic Chagas cardiomyopathy (CCC) or digestive forms like megaoesophagus and megacolon, while most infected patients (60%) remain asymptomatic (ASY) in the so‐called indeterminate form (IF). CCC is an inflammatory cardiomyopathy that occurs decades after the initial infection. Death results from heart failure or arrhythmia in a subset of CCC patients. Myocardial fibrosis, inflammation, and mitochondrial dysfunction are involved in heart failure and arrhythmia. Survival in CCC is worse than in other cardiomyopathies. Distinct from other cardiomyopathies, CCC displays a helper T‐cell type 1 (Th1‐T) cell–rich myocarditis with abundant interferon‐gamma (IFN‐ γ ) and tumor necrosis factor‐alpha (TNF‐ α ) and selectively lower levels of mitochondrial energy metabolism enzymes and high‐energy phosphates in the heart. A CD8+ T cell–rich inflammatory infiltrate has also been found in the Chagasic megaesophagus, which is associated with denervation of myoenteric plexi. IFN‐ γ and TNF‐ α signaling, which are constitutively upregulated in Chagas disease patients, negatively affect mitochondrial function and adenosine 5′‐triphosphate (ATP) production–cytokine‐induced mitochondrial dysfunction. In addition, the differential susceptibility to developing CCC has prompted many studies over the past 25 years on the association of genetic polymorphisms with disease outcomes. A comprehensive understanding of Chagas disease pathogenesis is crucial for identifying potential therapeutic targets. Genetic studies may offer valuable insights into factors with prognostic significance. In this review, we present an updated perspective on the pathogenesis and genetic factors associated with Chagas disease, emphasizing key studies that elucidate the differential progression of patients to CCC and other symptomatic forms. Furthermore, we explore the interplay between genetic susceptibility, inflammatory cytokines, mitochondrial dysfunction and discuss emerging therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunology, Heart Institute (InCor), University of São Paulo Medical School, São Paulo 05403-900, Brazil.
- French National Institute for Health and Medical Research (INSERM), UMR U1090, TAGC Theories and Approaches of Genomic Complexity, MarMaRa Institute, Aix Marseille University, Marseille 13288, France.
- Institute for Investigation in Immunology (III), National Institute of Science and Technology (INCT), São Paulo 05403-900, Brazil.
- Department of Clinical Immunology and Allergy, University of São Paulo Medical School, São Paulo 01246-903, Brazil.
ORCID-Profile: Amanda Farage Frade, Hélléa Guérin, Joao Paulo Silva Nunes, Luiz Felipe Souza E Silva, Vinicius Moraes de Paiva Roda, Rafael Pedro Madeira, Pauline Brochet, Pauline Andrieux, Jorge Kalil, Christophe Chevillard, Edecio Cunha-Neto
Förderung
- Institut National de la Santé et de la Recherche Médicale
- Aix-Marseille Université
- Agence Nationale de la Recherche
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Frade, A. F., Guérin, H., Nunes, J. P. S., Silva, L. F. S. E., Roda, V. M. P., Madeira, R. P., Brochet, P., Andrieux, P., Kalil, J., Chevillard, C., & Cunha-Neto, E. (2025). Cardiac and Digestive Forms of Chagas Disease: An Update on Pathogenesis, Genetics, and Therapeutic Targets. Mediators of Inflammation, 2025(1). https://doi.org/10.1155/mi/8862004
Vancouver
Frade AF, Guérin H, Nunes JPS, Silva LFSE, Roda VMP, Madeira RP, et al. Cardiac and Digestive Forms of Chagas Disease: An Update on Pathogenesis, Genetics, and Therapeutic Targets. Mediators of Inflammation. 2025;2025(1). doi:10.1155/mi/8862004
BibTeX
@article{Frade2025,
author = {Frade, Amanda Farage and Guérin, Hélléa and Nunes, Joao Paulo Silva and Silva, Luiz Felipe Souza E and Roda, Vinicius Moraes de Paiva and Madeira, Rafael Pedro and Brochet, Pauline and Andrieux, Pauline and Kalil, Jorge and Chevillard, Christophe and Cunha-Neto, Edecio},
title = {Cardiac and Digestive Forms of Chagas Disease: An Update on Pathogenesis, Genetics, and Therapeutic Targets},
journal = {Mediators of Inflammation},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/mi/8862004}
}
EUVIMED